ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 51 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $110,000 | -43.6% | 155,606 | +5.0% | 0.01% | -51.7% |
Q4 2021 | $195,000 | -42.8% | 148,131 | 0.0% | 0.03% | +20.8% |
Q3 2021 | $341,000 | -48.3% | 148,131 | -1.2% | 0.02% | -54.7% |
Q2 2021 | $659,000 | -63.7% | 150,000 | -40.0% | 0.05% | -13.1% |
Q1 2021 | $1,815,000 | – | 250,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |